Should the healthcare system support health and wellness data tracking for the purposes of long-term observational studies?
Advertisement
The Scientist
Most Recent
The current system by which academics publish their scientific discoveries is a massive waste of money.
Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Funding only outstanding researchers is increasing the gap between good and great labs and forcing some out of science in search of a bigger paycheck.
Designing the simplest possible living organism artificially may lend clues as to what life is.
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
Novel observations can sometimes be correct for unexpected reasons.
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.
Biomedical research can learn from citizen science, which is grounded in strong relationships with study participants.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
